AR018313A1 - Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo - Google Patents
Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivoInfo
- Publication number
- AR018313A1 AR018313A1 ARP990100933A ARP990100933A AR018313A1 AR 018313 A1 AR018313 A1 AR 018313A1 AR P990100933 A ARP990100933 A AR P990100933A AR P990100933 A ARP990100933 A AR P990100933A AR 018313 A1 AR018313 A1 AR 018313A1
- Authority
- AR
- Argentina
- Prior art keywords
- conceptive
- agent
- profile
- progestagenic
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98200744 | 1998-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018313A1 true AR018313A1 (es) | 2001-11-14 |
Family
ID=8233452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100933A AR018313A1 (es) | 1998-03-09 | 1999-03-05 | Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1061928A2 (de) |
| JP (1) | JP2002506014A (de) |
| KR (1) | KR20010041698A (de) |
| CN (1) | CN1292702A (de) |
| AR (1) | AR018313A1 (de) |
| AU (1) | AU756882B2 (de) |
| BR (1) | BR9908605A (de) |
| CA (1) | CA2319765A1 (de) |
| CO (1) | CO5070598A1 (de) |
| HU (1) | HUP0101007A3 (de) |
| ID (1) | ID25621A (de) |
| IL (1) | IL137541A0 (de) |
| NO (1) | NO20004492D0 (de) |
| NZ (1) | NZ506115A (de) |
| PE (1) | PE20000330A1 (de) |
| PL (1) | PL343428A1 (de) |
| RU (1) | RU2225714C2 (de) |
| TR (1) | TR200002593T2 (de) |
| WO (1) | WO1999045886A2 (de) |
| ZA (1) | ZA991851B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999051214A2 (en) * | 1998-04-07 | 1999-10-14 | Akzo Nobel N.V. | Progestogen-only contraceptive kit |
| NZ517281A (en) | 1999-09-06 | 2003-09-26 | Akzo Nobel Nv | Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| KR20030029640A (ko) | 2000-07-28 | 2003-04-14 | 악조 노벨 엔.브이. | 16 알파-메틸 또는 에틸 치환 에스트로겐 |
| EP1485103A1 (de) * | 2002-03-11 | 2004-12-15 | Janssen Pharmaceutica N.V. | Kontinuierliches sulfatase-hemmendes progestogen enthaltendes kontrazeptionsschema |
| WO2003077927A1 (en) * | 2002-03-11 | 2003-09-25 | Janssen Pharmaceutica N.V. | Sulfatase inhibiting progestogen-only contraceptive regimens |
| UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7701384A (nl) * | 1977-02-10 | 1978-08-14 | Akzo Nv | Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks. |
| DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
| ZA94715B (en) * | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
-
1999
- 1999-03-03 PL PL99343428A patent/PL343428A1/xx unknown
- 1999-03-03 CA CA002319765A patent/CA2319765A1/en not_active Abandoned
- 1999-03-03 IL IL13754199A patent/IL137541A0/xx unknown
- 1999-03-03 ID IDW20001715A patent/ID25621A/id unknown
- 1999-03-03 WO PCT/EP1999/001404 patent/WO1999045886A2/en not_active Application Discontinuation
- 1999-03-03 BR BR9908605-0A patent/BR9908605A/pt not_active IP Right Cessation
- 1999-03-03 KR KR1020007009917A patent/KR20010041698A/ko not_active Application Discontinuation
- 1999-03-03 TR TR2000/02593T patent/TR200002593T2/xx unknown
- 1999-03-03 HU HU0101007A patent/HUP0101007A3/hu unknown
- 1999-03-03 RU RU2000125572/15A patent/RU2225714C2/ru not_active IP Right Cessation
- 1999-03-03 JP JP2000535302A patent/JP2002506014A/ja not_active Withdrawn
- 1999-03-03 AU AU31437/99A patent/AU756882B2/en not_active Ceased
- 1999-03-03 NZ NZ506115A patent/NZ506115A/en unknown
- 1999-03-03 EP EP99939157A patent/EP1061928A2/de not_active Withdrawn
- 1999-03-03 CN CN998037710A patent/CN1292702A/zh active Pending
- 1999-03-05 AR ARP990100933A patent/AR018313A1/es not_active Application Discontinuation
- 1999-03-08 CO CO99014138A patent/CO5070598A1/es unknown
- 1999-03-08 ZA ZA9901851A patent/ZA991851B/xx unknown
- 1999-03-09 PE PE1999000186A patent/PE20000330A1/es not_active Application Discontinuation
-
2000
- 2000-09-08 NO NO20004492A patent/NO20004492D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20004492L (no) | 2000-09-08 |
| AU3143799A (en) | 1999-09-27 |
| BR9908605A (pt) | 2001-04-24 |
| HUP0101007A3 (en) | 2002-02-28 |
| NO20004492D0 (no) | 2000-09-08 |
| ID25621A (id) | 2000-10-19 |
| JP2002506014A (ja) | 2002-02-26 |
| AU756882B2 (en) | 2003-01-23 |
| PL343428A1 (en) | 2001-08-13 |
| ZA991851B (en) | 1999-09-22 |
| CN1292702A (zh) | 2001-04-25 |
| CA2319765A1 (en) | 1999-09-16 |
| PE20000330A1 (es) | 2000-05-16 |
| HUP0101007A2 (hu) | 2001-12-28 |
| TR200002593T2 (tr) | 2000-12-21 |
| RU2225714C2 (ru) | 2004-03-20 |
| KR20010041698A (ko) | 2001-05-25 |
| WO1999045886A2 (en) | 1999-09-16 |
| IL137541A0 (en) | 2001-07-24 |
| EP1061928A2 (de) | 2000-12-27 |
| WO1999045886A3 (en) | 1999-12-02 |
| NZ506115A (en) | 2003-07-25 |
| CO5070598A1 (es) | 2001-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| CR7420A (es) | Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12 | |
| DK1272504T3 (da) | 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener | |
| ES2191320T3 (es) | Derivados de piperazina y su uso como agentes anti-inflamatorios. | |
| EA200201000A1 (ru) | Гормон-заместительная терапия | |
| ECSP066972A (es) | Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos | |
| BRPI0517752B8 (pt) | processo para a preparação de drospirenona | |
| AR046671A1 (es) | Uso extendido de combinacion que comprende estrogenos y progestinas | |
| BRPI0512993A (pt) | uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto | |
| BR9911115A (pt) | Composições farmacêuticas e usos para oandrost-5-eno-3 beta, 17 beta-diol | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| AR040130A1 (es) | Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos | |
| UY26920A1 (es) | 7 - oxo piridopirimidinas | |
| PA8633601A1 (es) | Profarmacos de esteroides con accion androgenica | |
| AR018313A1 (es) | Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo | |
| CY1110173T1 (el) | Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης | |
| PT1421099E (pt) | Esteres de 17-alfa, 21-di-hidroxipregneno como agentes anti-androgenicos | |
| UY28910A1 (es) | Prodrogas de estriol y estetrol | |
| AR046672A1 (es) | Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol | |
| BR0013769A (pt) | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide | |
| AR040188A1 (es) | Estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva | |
| ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest | |
| BR0116127A (pt) | Composto, composição farmacêutica, uso de um composto, e, conjunto para a contracepção masculina | |
| AR048829A1 (es) | 17alfa - fluoroesteroides con actividad inhibidora de 5 alfa-reductasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades cancerosas influidas por androgenos. | |
| PE20020520A1 (es) | Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |